MMP9 and acute coronary syndrome: Disturbed equilibrium of the metalloproteinase/tissue inhibitors system, destabilization of atherosclerotic plaque, and acute coronary syndrome (ACS) in patients are caused by increased expression of MMP-2 and MMP-9 metalloproteinases and their tissue inhibitor (TIMP-2) [140].